Treatment of UTI in Pregnancy
Nitrofurantoin (50-100 mg four times daily for 5-7 days) or fosfomycin (3g single dose) are the first-line treatments for UTI in pregnancy, with cephalosporins (such as cephalexin 500 mg four times daily for 7-14 days) as appropriate alternatives. 1, 2
Antibiotic Selection by Trimester
First Trimester
- Nitrofurantoin is the preferred first-line agent for uncomplicated UTI in the first trimester 1
- Fosfomycin trometamol (3g single dose) is an acceptable alternative with the advantage of single-dose administration 1, 2
- Cephalosporins (cephalexin, cefpodoxime, cefuroxime) are appropriate alternatives if nitrofurantoin or fosfomycin cannot be used 1
- Avoid trimethoprim-sulfamethoxazole in the first trimester due to potential teratogenic effects 1, 2
- Avoid fluoroquinolones throughout all trimesters due to potential adverse effects on fetal cartilage development 1
Second Trimester
- Same antibiotic options as first trimester apply 1, 2
- Nitrofurantoin, fosfomycin, and cephalosporins remain safe and effective 1
Third Trimester
- Cephalexin (500 mg four times daily for 7-14 days) becomes the preferred first-line agent in the third trimester 1
- Avoid nitrofurantoin near term due to risk of hemolytic anemia in the newborn 2
- Fosfomycin (3g single dose) can be considered for uncomplicated lower UTIs, though clinical data is more limited than for cephalosporins 1
- Amoxicillin-clavulanate (20-40 mg/kg per day in 3 doses) is appropriate if the pathogen is susceptible 1
- Avoid trimethoprim-sulfamethoxazole in the third trimester due to risk of neonatal hyperbilirubinemia and kernicterus 1, 2
Treatment Duration
- Standard treatment course is 7-14 days for symptomatic UTI in pregnancy 1
- 5-7 days is acceptable depending on the antimicrobial chosen 1, 2
- Shorter courses (1-3 days) are generally not recommended for pregnant women 2
- Single-dose fosfomycin is the exception to multi-day regimens and is equally effective for uncomplicated cystitis 2
Diagnostic Requirements
- Always obtain urine culture before initiating treatment to guide antibiotic selection and confirm diagnosis 1, 2
- Optimal screening timing is at 12-16 weeks gestation 1
- Screening for pyuria alone has only 50% sensitivity for identifying bacteriuria and is inadequate 1
- Obtain follow-up urine culture 1-2 weeks after completing treatment to confirm cure 1
Special Clinical Scenarios
Asymptomatic Bacteriuria (ASB)
- Pregnancy is the one clinical scenario where ASB must always be treated due to significant risk for progression to pyelonephritis and adverse pregnancy outcomes 1, 2
- Untreated bacteriuria increases pyelonephritis risk 20-30 fold (from 1-4% with treatment to 20-35% without) 1
- Treatment reduces premature delivery and low birth weight infants 1
- Use the same antibiotic options and duration as for symptomatic UTI 1, 2
Group B Streptococcus (GBS) Bacteriuria
- GBS bacteriuria in any concentration during pregnancy requires treatment at diagnosis AND intrapartum prophylaxis during labor 1
- GBS bacteriuria is a marker for heavy genital tract colonization 1
Suspected Pyelonephritis
- Do not use nitrofurantoin for suspected pyelonephritis as it does not achieve therapeutic concentrations in the bloodstream 1
- Initial parenteral therapy may be required, with transition to oral therapy after clinical improvement 1
- Cephalosporins achieve adequate blood and urinary concentrations and are appropriate for pyelonephritis 1
Recurrent UTIs
- Consider prophylactic antibiotics (cephalexin) for the remainder of pregnancy in cases of recurrent UTIs 1
- Daily low-dose antibiotics can be used in select cases with frequent recurrences 2
- Do not perform surveillance urine testing or treat ASB repeatedly after the initial screen-and-treat approach, as this fosters antimicrobial resistance 1
Penicillin Allergy Considerations
- Only 10% of penicillin-allergic patients have reactions to cephalosporins 1
- Assess whether the patient is at high risk for anaphylaxis; if not, cephalosporins are safe 1
- If true severe penicillin allergy exists, nitrofurantoin or fosfomycin are appropriate alternatives 1, 2
Critical Pitfalls to Avoid
- Never delay treatment in pregnant women with symptomatic UTI, as this increases the risk of pyelonephritis and adverse pregnancy outcomes 1
- Do not use antibiotics that fail to achieve adequate urinary concentrations (such as certain macrolides) 2
- Do not classify all pregnant women with UTIs as requiring broad-spectrum antibiotics unless they have structural/functional urinary tract abnormalities or immunosuppression 1
- Antibiotic choice must consider local resistance patterns and patient-specific factors such as allergies 1, 2